glp-1 microdosing vs full dose Microdosing: Risks, Benefits and What to Know Before Changing Your People Are Microdosing Weight-Loss Drugs

As our bodies adapt to the new life growing within, they face increased oxidative stress from various sources, including environmental toxins and metabolic changes

Achieving some healthy lifestyle behaviors can lower the risk of a major adverse cardiovascular event, Nguyen said

The market, valued at several billion dollars, continues to grow as more consumers seek to improve the health of their skin, joints, and bones

GLP-1 agonists enhance insulin secretion from pancreatic beta cells only when blood glucose levels are elevated, a mechanism termed "glucose-dependent insulinotropic action." This physiological approach reduces the risk of hypoglycemia compared with sulfonylureas or exogenous insulin, though the risk increases when GLP-1 agents are combined with insulin or sulfonylureas, potentially requiring dose adjustments of these medications